| Product Name | MF | CAS | Details |
|---|
| R-Tetrahydropapaverine N-acetyl-L-leucinate | C28H40N2O7 | 141109-12-8 | Details |
| H-CEDIASIAPFLNALE-OH | Details |
| Bacillus anthracis (Anthrax) antibody (Lethal Factor) | Details |
| 4-Methyl-2-azabicyclo[2.1.1]hexane-1-carboxylic acid hydrochloride | C7H12ClNO2 | 1955540-92-7 | Details |
| ERI1 antibody | Details |
| Methyl 2-(1H-pyrazol-5-yl)acetate | C6H8N2O2 | 878678-79-6 | Details |
| (7S,8aS)-7-Fluoro-octahydropyrrolo[1,2-a]pyrazine dihydrochloride | C7H14ClFN2 | 1807939-68-9 | Details |
| ethyl 2-((4-chlorophenyl)amino)-5-oxo-3-oxolenecarboxylate | C13H12ClNO4 | 58337-17-0 | Details |
| 2'-O-tert-Butyldimethylsilyl-5'-O-DMT-N2-methylguanosine 3'-CE phosphoramidite | Details |
| H-Phe-Pro-bNA·HCl | C24H25N3O2 | 76122-99-1 | Details |
| 6-Bromo-5-methoxy-1,3-benzothiazol-2-amine | C8H7BrN2OS | 1092120-21-2 | Details |
| USP12 antibody | Details |
| 4-Cyano-3,5-difluorophenol | C7H3F2NO | 123843-57-2 | Details |
| 1,4,8-Oxadiazecan-5-one | C7H14N2O2 | 2044713-53-1 | Details |
| H-AITEVECFL-OH | Details |
| 3-Methylcyclohex-2-en-1-one | C7H10O | 1193-18-6 | Details |
| 2-(Boc-amino)-2-(3-pyridinyl)acetic acid | C12H16N2O4 | 347187-29-5 | Details |
| 5-Amino-1,3-dimethyl-1H-pyrazole-4-carbaldehyde | C6H9N3O | 57411-70-8 | Details |
| TNR antibody | Details |
| Clovoxamine-d3 | C14H21ClN2O2 | 1185246-59-6 | Details |
| Simvastatin acyl-b-D-glucuronide | C31H48O12 | 463962-56-3 | Details |
| Gefitinib-d3 | C22H24ClFN4O3 | 1173976-40-3 | Details |
| 6'-Hydroxy buspirone | C21H31N5O3 | 125481-61-0 | Details |
| Dithiouracil | C4H4N2S2 | 2001-93-6 | Details |
| H-RPMTYKAAVDLSHFL-OH | Details |
| 2-Hydroxy-5-{[(2,2,2-trifluoroethoxy)carbonyl]amino}benzoic acid | C10H8F3NO5 | 1291500-95-2 | Details |
| 2-Ethyl-5-phenylisoxazolium-3'-sulfonate | C11H11NO4S | 4156-16-5 | Details |
| (1S)-1-(5-Chlorothiophen-2-yl)ethan-1-amine hydrochloride | C6H9Cl2NS | 1432681-27-0 | Details |
| 2-[4-(Bromomethyl)phenoxy]acetonitrile | C9H8BrNO | 1092078-26-6 | Details |
| 3-(Difluoromethyl)piperidine hydrochloride | C6H12ClF2N | 1427455-16-0 | Details |
| 3-(Cyclopropylmethyl)-1-phenyl-1H-pyrazol-5-amine | C13H15N3 | 1250517-20-4 | Details |
| 6-Methoxyflavone | C16H12O3 | 26964-24-9 | Details |
| RABGAP1L antibody | Details |
| 2-bromo-5-fluoropyridine-3-carbonitrile | C6H2BrFN2 | 1305208-36-9 | Details |
| LAIR2 Blocking Peptide | Details |
| 4-(Dimethylamino)-1-phenylbutan-2-one hydrochloride | C12H18ClNO | 103960-48-1 | Details |
| 3,4-Dihydroxyphenylacetic acid | C8H8O4 | 102-32-9 | Details |
| 4-Chloro-5,8-difluoroquinoline-3-carbonitrile | C10H3ClF2N2 | 936497-95-9 | Details |
| NSUN5 antibody | Details |
| Dimethylglyoxime disodium salt octahydrate | C4H22N2Na2O10 | 75006-64-3 | Details |
| 5-Methyl-3-(pyrrolidin-2-yl)-1,2,4-oxadiazole | C7H11N3O | 1316227-35-6 | Details |
| rac-(1R,3S)-3-(Hydroxymethyl)cyclohexan-1-ol | C7H14O2 | 15753-48-7 | Details |
| anti-human TNF-α antibody | Details |
| H-EEKRGSLYVW-OH | Details |
| 1,2-Dipalmitoyl-rac-glycero-3-phosphoethanolamine | C37H74NO8P | 5681-36-7 | Details |
| 2-Chloro-4-cyclopropyl-1,3-thiazole | C6H6ClNS | 1344072-01-0 | Details |
| N-(3,5-bis(trifluoromethyl)phenyl)-2-(4-phenylpiperazinyl)ethanamide | C20H19F6N3O | 329778-87-2 | Details |
| (4-Difluoromethanesulfonylphenyl)methyl acetate | C10H10F2O4S | 1221722-64-0 | Details |
| ZNF417 antibody | Details |
| Azide-PEG12-Tos | C31H55N3O14S | 1821464-56-5 | Details |
| 3,4-Dihydroxybenzoic acid ethyl ester | C9H10O4 | 3943-89-3 | Details |
| Letosteine | C10H17NO4S2 | 53943-88-7 | Details |
| Cephalothin sodium | C16H16N2O6S2.Na | 58-71-9 | Details |
| CDK 4/6 Inhibitor-D6 | C22H29ClN8 | 1256963-02-6 | Details |
| Eriosematin A | C14H14O4 | 175448-02-9 | Details |
| Methyl 3-(1,2,4-oxadiazol-5-yl)benzoate | C10H8N2O3 | 1354951-60-2 | Details |
| 5-[2-(1,3-Dioxaindan-5-yl)ethyl]-5-methylimidazolidine-2,4-dione | C13H14N2O4 | 1052562-60-3 | Details |
| CM 11 | C58H82N8O14S2 | 2244684-49-7 | Details |
| 4-Nitro-3-(trifluoromethyl)aniline (FLU-1) | C7H5F3N2O2 | 393-11-3 | Details |
| 2-(Difluoromethoxy)-5-nitrobenzaldehyde | C8H5F2NO4 | 145742-63-8 | Details |
| 4-Bromo-5-methyl-3-phenyl-1,2-oxazole | C10H8BrNO | 31295-65-5 | Details |
| Dehydrocrebanine | C20H19NO4 | 77784-22-6 | Details |
| H-Met-Trp-OH | C16H21N3O3S | 60535-02-6 | Details |
| D-Cellobiose | C12H22O11 | 528-50-7 | Details |
| 8-Ethyl-1,2,3,4-tetrahydroquinoline | C11H15N | 103858-38-4 | Details |
| RFXB antibody | Details |
| PRR15 Blocking Peptide | Details |
| Tetrabutylammonium fluoride - 1.0M in THF | C16H36FN | 429-41-4 | Details |
| Apterin | C20H24O10 | 53947-89-0 | Details |
| Tetracycline-HRP | Details |
| tert-Butyl 2-methylazetidine-2-carboxylate hydrochloride | 2228604-50-8 | Details |
| 3-Methyl-4-(2,2,2-trifluoroethoxy)aniline | C9H10F3NO | 1094646-56-6 | Details |
| CSRP1 antibody (biotin) | Details |
| tert-Butyl 2-[(3-methoxy-3-oxopropyl)carbamoyl]pyrrolidine-1-carboxylate | C14H24N2O5 | 1461705-43-0 | Details |
| 8-Oxa-4-azaspiro[2.6]nonane hydrochloride | C7H14ClNO | 1803561-68-3 | Details |
| 3-{2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecan-1-yl}propan-1-amine | C9H20N2O3Si | 17869-27-1 | Details |
| 3-Nitro-N-methylaniline | C7H8N2O2 | 619-26-1 | Details |
| 2-[(1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)methyl]-1,3-thiazole-4-carboxylic acid | 2138331-77-6 | Details |
| (4,5-Dichlorothiophen-2-yl)boronic acid | C4H3BCl2O2S | 1190737-21-3 | Details |
| 4-[(1H-Pyrazol-1-yl)methyl]phenol | C10H10N2O | 80200-09-5 | Details |
| 5-Methyl-2,1,3-benzothiadiazole-4-sulfonyl chloride | C7H5ClN2O2S2 | 3662-82-6 | Details |
| (Dimethyl-1H-1,2,3-triazol-5-yl)methanol | C5H9N3O | 1823967-14-1 | Details |
| 1,4-Dimethyl-3-phenyl-1H-pyrazole-5-carboxylic acid | C12H12N2O2 | 93618-41-8 | Details |
| 4-Oxo-5-hexenoic acid | C6H8O3 | 6934-64-1 | Details |
| H-GQNDTSQTSSPS-Phosphocolamine | Details |
| SAV1 antibody | Details |
| 1-Methyl-5-phenyl-2,3-dihydro-1H-imidazol-2-one | C10H10N2O | 59167-84-9 | Details |
| 4-[(Cyclopropylcarbamoyl)amino]benzoic acid | C11H12N2O3 | 1087784-47-1 | Details |
| Methyl 2-amino-3-(4-fluoro-1H-indol-3-yl)propanoate | C12H13FN2O2 | 1313033-01-0 | Details |
| Benzyl 2-oxoacetate | C9H8O3 | 52709-42-9 | Details |
| (2-Amino-3-phenylpropyl)(2-ethoxyethyl)methylamine | C14H24N2O | 1533067-36-5 | Details |
| CYP27A1 Blocking Peptide | Details |
| Methyl(4-methylpentyl)amine hydrochloride | 2172584-71-1 | Details |
| 4-(2,3-Dihydro-1H-indol-1-yl)butanoic acid hydrochloride | C12H16ClNO2 | 1059626-21-9 | Details |
| 3-Iodo-1-(2-methoxyethyl)-1H-pyrazole | C6H9IN2O | 1512429-29-6 | Details |
| tert-Butyl 2-(4-bromophenyl)acetate | C12H15BrO2 | 33155-58-7 | Details |
| tert-Butyl (2S,4S)-2,4-bis(hydroxymethyl)azetidine-1-carboxylate | C10H19NO4 | 1036262-54-0 | Details |
| 2-[2-(3,3,3-Trifluoropropyl)-1,3-thiazol-4-yl]acetic acid hydrochloride | C8H9ClF3NO2S | 2060060-40-2 | Details |
| 1-Propyl-3-piperidone hydrochloride hydrate | C8H18ClNO2 | 321141-29-1 | Details |
| C17ORF64 antibody | Details |
| Product Total： Product Page： | ||||
| 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 | ||||